Pneumonia pathophysiology: Difference between revisions
Hamid Qazi (talk | contribs) No edit summary |
Aditya Ganti (talk | contribs) |
||
Line 9: | Line 9: | ||
===Mode of Transmission=== | ===Mode of Transmission=== | ||
=====1. Inhalation of Aerosolized Droplets===== | =====1. Inhalation of Aerosolized Droplets===== | ||
[[Inhalation]] of aerosolized droplets of 0.5 to 1 micrometer is the most common pathway of acquiring [[pneumonia]]. A few [[Bacteria|bacterial]] and [[Virus|viral]] [[Infection|infections]] are transmitted in this fashion. The [[lung]] can normally filter out particles between 0.5 to 2 micrometer by recruiting the [[Alveolus|alveolar]] [[macrophages]].<ref name="Wunderink-2004">{{Cite journal | last1 = Wunderink | first1 = RG. | last2 = Waterer | first2 = GW. | title = Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections. | journal = Infect Dis Clin North Am | volume = 18 | issue = 4 | pages = 743-59, vii | month = Dec | year = 2004 | doi = 10.1016/j.idc.2004.07.004 | PMID = 15555822 }}</ref> | * [[Inhalation]] of aerosolized droplets of 0.5 to 1 micrometer is the most common pathway of acquiring [[pneumonia]]. | ||
* A few [[Bacteria|bacterial]] and [[Virus|viral]] [[Infection|infections]] are transmitted in this fashion. | |||
* The [[lung]] can normally filter out particles between 0.5 to 2 micrometer by recruiting the [[Alveolus|alveolar]] [[macrophages]].<ref name="Wunderink-2004">{{Cite journal | last1 = Wunderink | first1 = RG. | last2 = Waterer | first2 = GW. | title = Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections. | journal = Infect Dis Clin North Am | volume = 18 | issue = 4 | pages = 743-59, vii | month = Dec | year = 2004 | doi = 10.1016/j.idc.2004.07.004 | PMID = 15555822 }}</ref> | |||
=====2. Microaspiration of Oropharyngeal Contents===== | =====2. Microaspiration of Oropharyngeal Contents===== | ||
[[Aspiration pneumonia|Aspiration]] of [[Oropharyngeal airway|oropharyngeal]] contents containing pathogenic microorganisms is one of the mechanism of acquiring [[pneumonia]]. It most commonly occurs in normal persons during [[sleep]], in unconscious persons due to [[Gastroesophageal reflux disease|gastroesopahegeal reflux]] or impaired [[gag reflex]] and [[cough reflex]].<ref name="Wunderink-2004">{{Cite journal | last1 = Wunderink | first1 = RG. | last2 = Waterer | first2 = GW. | title = Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections. | journal = Infect Dis Clin North Am | volume = 18 | issue = 4 | pages = 743-59, vii | month = Dec | year = 2004 | doi = 10.1016/j.idc.2004.07.004 | PMID = 15555822 }}</ref> | * [[Aspiration pneumonia|Aspiration]] of [[Oropharyngeal airway|oropharyngeal]] contents containing pathogenic microorganisms is one of the mechanism of acquiring [[pneumonia]]. | ||
* It most commonly occurs in normal persons during [[sleep]], in unconscious persons due to [[Gastroesophageal reflux disease|gastroesopahegeal reflux]] or impaired [[gag reflex]] and [[cough reflex]].<ref name="Wunderink-2004">{{Cite journal | last1 = Wunderink | first1 = RG. | last2 = Waterer | first2 = GW. | title = Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections. | journal = Infect Dis Clin North Am | volume = 18 | issue = 4 | pages = 743-59, vii | month = Dec | year = 2004 | doi = 10.1016/j.idc.2004.07.004 | PMID = 15555822 }}</ref> | |||
=====3. Blood-Borne or Systemic Infection===== | =====3. Blood-Borne or Systemic Infection===== | ||
Microbial entered through circulation may also result in [[Lung|pulmonary]] [[Infection|infections]]. Blood-borne pneumonia is seen more commonly in intravenous drug users. [[Staphylococcus aureus]] causes pneumonia in this way. [[Gram negative bacteria]] typically account for pneumonia in [[immunocompromised]] individuals. | * Microbial entered through circulation may also result in [[Lung|pulmonary]] [[Infection|infections]]. | ||
* Blood-borne pneumonia is seen more commonly in intravenous drug users. [[Staphylococcus aureus]] causes pneumonia in this way. | |||
* [[Gram negative bacteria]] typically account for pneumonia in [[immunocompromised]] individuals. | |||
=====4. Trauma or Local Spread===== | =====4. Trauma or Local Spread===== | ||
Pneumonia can occur after a [[Lung|pulmonary]] procedure or a penetrating trauma to the [[Lung|lungs]]. A local spread of a [[hepatic abscess]] can also lead to pneumonia. | * Pneumonia can occur after a [[Lung|pulmonary]] procedure or a penetrating trauma to the [[Lung|lungs]]. | ||
* A local spread of a [[hepatic abscess]] can also lead to pneumonia. | |||
===Agent Specific Virulence Factors=== | ===Agent Specific Virulence Factors=== |
Latest revision as of 20:48, 11 November 2018
Pneumonia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pneumonia pathophysiology On the Web |
American Roentgen Ray Society Images of Pneumonia pathophysiology |
Risk calculators and risk factors for Pneumonia pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2], Priyamvada Singh, M.D. [3]
Overview
Bacteria and fungi typically enter the lung with inhalation. Once inside the alveoli, these microbes travel into the spaces between the cells and also between adjacent alveoli through connecting pores. This invasion triggers the immune system response by sending white blood cells responsible for attacking microorganisms (neutrophils) to the lungs resulting in manifestations of pneumonia.
Pathophysiology
Mode of Transmission
1. Inhalation of Aerosolized Droplets
- Inhalation of aerosolized droplets of 0.5 to 1 micrometer is the most common pathway of acquiring pneumonia.
- A few bacterial and viral infections are transmitted in this fashion.
- The lung can normally filter out particles between 0.5 to 2 micrometer by recruiting the alveolar macrophages.[1]
2. Microaspiration of Oropharyngeal Contents
- Aspiration of oropharyngeal contents containing pathogenic microorganisms is one of the mechanism of acquiring pneumonia.
- It most commonly occurs in normal persons during sleep, in unconscious persons due to gastroesopahegeal reflux or impaired gag reflex and cough reflex.[1]
3. Blood-Borne or Systemic Infection
- Microbial entered through circulation may also result in pulmonary infections.
- Blood-borne pneumonia is seen more commonly in intravenous drug users. Staphylococcus aureus causes pneumonia in this way.
- Gram negative bacteria typically account for pneumonia in immunocompromised individuals.
4. Trauma or Local Spread
- Pneumonia can occur after a pulmonary procedure or a penetrating trauma to the lungs.
- A local spread of a hepatic abscess can also lead to pneumonia.
Agent Specific Virulence Factors
Several strategies are evolved to evade host defence mechanisms and facilitate spreading before establishing an infection.
- Influenza virus possesses neuraminidases for cleavage of sialic acid residues on the cell surface and viral proteins, which prevent aggregation and facilitate propagation of viral particles.
- Chlamydophila pneumoniae induces complete abortion of cilia motions which assists colonization at the respiratory epithelium.[2]
- Mycoplasma pneumoniae produces a virulence factor with ADP-ribosylating activity which is responsible for airway cellular damage and mucociliary dysfunction.[3]
- Haemophilus influenzae, Streptococcus pneumoniae, and Neisseria meningitidis produce proteases that split mucosal IgA.
- Streptococcus pneumoniae possesses pneumolysin that aid the bacteria during colonization, by facilitating adherence to the host,[4] during invasion by damaging host cells,[5] and during infection by interfering with the host immune response.[6]
Host Factors
- The lungs can normally filter out large droplets of aerosols.
- Smaller droplets of the size of 0.5 to 2 micrometer are deposited on the alveoli and then engulfed by alevolar macrophages.
- These macrophages release cytokines and chemokines, which also includes tumor necrosis factor-alpha, interleukin-8 and LTB4.
- The neutrophils are recruited by these cells to eliminate these microorganisms.[7][8]
1. Diminished Mucociliary Clearance
- The cilia lining the respiratory epithelium serve to move secreted mucus containing trapped foreign particles including pathogens towards the oropharynx for either expectoration or swallowing.
- Elevated incidence of pneumonia in patients with genetic defects affecting mucociliary clearance such as primary ciliary dyskinesia suggests its role in the pathogenesis of community-acquired pneumonia.
2. Impaired Cough Reflex
- Cough, together with mucociliary clearance, prevent pathogens from entering the lower respiratory tract.
- Cough suppression or cough reflex inhibition seen in patients with cerebrovascular accidents and drug overdosages is associated with an enhanced risk for aspiration pneumonia.
- Another relation to cough is genetic polymorphisms in the angiotensin-converting enzyme (ACE) gene.
- The role of cough in preventing pneumonia may be explained by a higher risk for developing pneumonia in homozygotes carrying deletion/deletion (DD) genotype who are found to have lower levels of bradykinin and tachykinins such as substance P.[9][10]
3. Defective Immune System
- Pathogen-associated molecular patterns (PAMPs) are initially recognized by Toll-like receptors (TLRs) and other pattern-recognition receptors (PRRs) of the innate immune system.
- Effectors in the acquired immune system are involved in elimination of microorganisms and generation of immunological memory.
- Other components in the immune system such as complement system, cytokines, and collectins, also mediate the defense against microorganisms causing pneumonia.
Microscopic Pathology
Microbial PathogenesisVirulence FactorsSeveral mechanisms have evolved to evade host defense mechanisms and facilitate microbial spread to establish an infection.
Aspiration Pneumonia{{#ev:youtube|bTqgAfQv0p4}}
Lobar Pneumonia{{#ev:youtube|dxXrxYIXbL8}} Pneumocystis Pneumonia{{#ev:youtube|KfF_pPUjR8o}} Pneumocystis Pneumonia{{#ev:youtube|zSdK_yWe_S4}} Aspiration Pneumonia{{#ev:youtube|bTqgAfQv0p4}} Aspiration Pneumonia, Infant{{#ev:youtube|RXnnEuEZ0BY}} Desquamative Interstitial Pneumonia{{#ev:youtube|G0TFmAAYjWU}} Legionella Pneumonia{{#ev:youtube|BDWEnPilfIQ}} Measles Pneumonia{{#ev:youtube|v80kA_dt6EE}} Abscess, Bronchopneumonia{{#ev:youtube|wO2x7O2KEZY}} |
References
- ↑ 1.0 1.1 Wunderink, RG.; Waterer, GW. (2004). "Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections". Infect Dis Clin North Am. 18 (4): 743–59, vii. doi:10.1016/j.idc.2004.07.004. PMID 15555822. Unknown parameter
|month=
ignored (help) - ↑ 2.0 2.1 Shemer-Avni, Y.; Lieberman, D. (1995). "Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells". J Infect Dis. 171 (5): 1274–8. PMID 7751703. Unknown parameter
|month=
ignored (help) - ↑ 3.0 3.1 Kannan, TR.; Baseman, JB. (2006). "ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens". Proc Natl Acad Sci U S A. 103 (17): 6724–9. doi:10.1073/pnas.0510644103. PMID 16617115. Unknown parameter
|month=
ignored (help) - ↑ Rubins, JB (December 1998). "Pneumolysin in pneumococcal adherence and colonization". Microbial pathogenesis. 25 (6): 337–42. doi:10.1006/mpat.1998.0239. PMID 9895272. Unknown parameter
|coauthors=
ignored (help) - ↑ Rubins, JB (January 1998). "Pneumolysin: a multifunctional pneumococcal virulence factor". The Journal of laboratory and clinical medicine. 131 (1): 21–7. PMID 9452123. Unknown parameter
|coauthors=
ignored (help) - ↑ Cockeran, R (June 2002). "The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection". Current Opinion in Infectious Diseases. 15 (3): 235–9. PMID 12015456. Unknown parameter
|coauthors=
ignored (help) - ↑ Strieter, RM.; Belperio, JA.; Keane, MP. (2003). "Host innate defenses in the lung: the role of cytokines". Curr Opin Infect Dis. 16 (3): 193–8. doi:10.1097/01.qco.0000073766.11390.0e. PMID 12821807. Unknown parameter
|month=
ignored (help) - ↑ Mason, CM.; Nelson, S. (2005). "Pulmonary host defenses and factors predisposing to lung infection". Clin Chest Med. 26 (1): 11–7. doi:10.1016/j.ccm.2004.10.018. PMID 15802161. Unknown parameter
|month=
ignored (help) - ↑ Morimoto, S.; Okaishi, K.; Onishi, M.; Katsuya, T.; Yang, J.; Okuro, M.; Sakurai, S.; Onishi, T.; Ogihara, T. (2002). "Deletion allele of the angiotensin-converting enzyme gene as a risk factor for pneumonia in elderly patients". Am J Med. 112 (2): 89–94. PMID 11835945. Unknown parameter
|month=
ignored (help) - ↑ Rigat, B.; Hubert, C.; Alhenc-Gelas, F.; Cambien, F.; Corvol, P.; Soubrier, F. (1990). "An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels". J Clin Invest. 86 (4): 1343–6. doi:10.1172/JCI114844. PMID 1976655. Unknown parameter
|month=
ignored (help) - ↑ Rubins, JB (December 1998). "Pneumolysin in pneumococcal adherence and colonization". Microbial pathogenesis. 25 (6): 337–42. doi:10.1006/mpat.1998.0239. PMID 9895272. Unknown parameter
|coauthors=
ignored (help) - ↑ Rubins, JB (January 1998). "Pneumolysin: a multifunctional pneumococcal virulence factor". The Journal of laboratory and clinical medicine. 131 (1): 21–7. PMID 9452123. Unknown parameter
|coauthors=
ignored (help) - ↑ Cockeran, R (June 2002). "The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection". Current Opinion in Infectious Diseases. 15 (3): 235–9. PMID 12015456. Unknown parameter
|coauthors=
ignored (help)